Search

A new drug could be an effective treatment for some people with low-grade glioma.

… Wednesday, August 7, 2024 Brain tumors are among the deadliest and most difficult cancers to treat. But the US Food and Drug Administration (FDA) has now approved a new drug that slows the growth of low-grade diffuse gliomas with a certain gene mutation.  “This represents the first new treatment option

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

… Wednesday, December 28, 2016 Immunologists are fond of car analogies. The T cells that protect us from infections and cancer, they say, have an ignition switch. They also have gas pedals and brakes. How immunologists, like good molecular mechanics, deciphered what makes T cells hum is a story that reaches

Cell replacement therapy seeks to restore function in the body by replacing cells that are lost due to disease or injury with new, healthy cells. One disease for which this type of therapy holds particular promise is the degenerative neurological disorder Parkinson’s disease, which is characterized by symptoms related to movement.

… Tuesday, August 21, 2012 Summary Cell replacement therapy seeks to restore function in the body by replacing cells that are lost due to disease or injury with new, healthy cells. One disease for which this type of therapy holds particular promise is the degenerative neurological disorder Parkinson’s

Studies conducted in mice reveal a potential way to breach the defenses of pancreatic cancer tumors.

… Tuesday, March 31, 2020 Summary In a study published March 31, researchers at the Sloan Kettering Institute report that a two-drug combination makes pancreatic cancer more sensitive to immunotherapy in mouse models. Pancreatic cancer is one of the most challenging cancers to treat. In part, that’s because

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.

… Thursday, December 14, 2023 Non-small cell lung cancer (NSCLC) , the most common form of lung cancer , is often diagnosed at an advanced  stage . About half the time, it has already spread around the body and has reached stage 4. The standard treatment for most patients with metastatic NSCLC is systemic

Obtenga información sobre cómo la radiación intensamente focalizada y de alta dosis puede detener el crecimiento del cáncer pulmonar después de que se ha diseminado a una pequeña cantidad de sitios.

… Thursday, December 14, 2023 El cáncer pulmonar de células no pequeñas (CPCNP) , la forma más común de cáncer pulmonar , suele diagnosticarse en un estadio  avanzado . Aproximadamente la mitad de las veces, ya se ha diseminado por el cuerpo y ha alcanzado el estadio 4. El tratamiento convencional para

Memorial Sloan Kettering Cancer Center (MSK) is partnering with PathPresenter, a leader in digital pathology workflow software, to integrate DeepLIIF, MSK’s new artificial intelligence (AI) algorithm, into PathPresenter’s image management platform for oncology research.

… Monday, April 14, 2025 Memorial Sloan Kettering Cancer Center (MSK) is partnering with PathPresenter, a leader in digital pathology workflow software, to integrate DeepLIIF, MSK’s new artificial intelligence (AI) algorithm, into PathPresenter’s image management platform for oncology research. DeepLIIF

… Thursday, October 6, 2022 Perry Ortiz doesn’t remember having a seizure in 2016. Or being rushed to an operating room, where doctors confirmed Perry — a security supervisor at Memorial Sloan Kettering Cancer Center (MSK) — had stage 2 testicular cancer . His only recollection of that day six years ago

The US Food and Drug Administration has updated its recommendations for the use of Gardasil 9, the vaccine that protects against human papillomavirus (HPV), to include people age 27 to 45. Previously, Gardasil 9 was only approved for use in those between age nine and 26. 

… Thursday, October 18, 2018 The US Food and Drug Administration has updated its recommendations for the use of Gardasil 9, the vaccine that protects against human papillomavirus (HPV), to include people age 27 to 45. Previously, Gardasil 9 was only approved for use in those between age nine and 26.  This

Read about a new discovery that could lead to more powerful cell-based therapies for cancer.

… Tuesday, July 22, 2025 A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically engineered immune cells sometimes fail to finish the job when given as a cancer treatment. The new discovery sheds light on the tendency of these modified cells